China Oncology Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Oncology Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Oncology Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Oncology Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • HENGRUI

    • GuiZhou YiBai

    • Lunan

    • Eli Lilly and Company

    • Roche

    • QILU

    • LUYE

    • Novartis

    • Sanofi

    • AstraZeneca

    • HANSOH

    By Type:

    • Antimetabolite

    • Alkaloid drugs

    • Hormone

    • Targeted drug

    • Platinum-based drugs

    • Other

    By End-User:

    • Blood Cancer

    • Breast Cancer

    • Gastrointestinal Cancer

    • Prostate Cancer

    • Respiratory/Lung Cancer

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Oncology Drugs Market Size and Growth Rate of Antimetabolite from 2016 to 2027

    • 1.3.2 China Oncology Drugs Market Size and Growth Rate of Alkaloid drugs from 2016 to 2027

    • 1.3.3 China Oncology Drugs Market Size and Growth Rate of Hormone from 2016 to 2027

    • 1.3.4 China Oncology Drugs Market Size and Growth Rate of Targeted drug from 2016 to 2027

    • 1.3.5 China Oncology Drugs Market Size and Growth Rate of Platinum-based drugs from 2016 to 2027

    • 1.3.6 China Oncology Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Oncology Drugs Market Size and Growth Rate of Blood Cancer from 2016 to 2027

    • 1.4.2 China Oncology Drugs Market Size and Growth Rate of Breast Cancer from 2016 to 2027

    • 1.4.3 China Oncology Drugs Market Size and Growth Rate of Gastrointestinal Cancer from 2016 to 2027

    • 1.4.4 China Oncology Drugs Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

    • 1.4.5 China Oncology Drugs Market Size and Growth Rate of Respiratory/Lung Cancer from 2016 to 2027

    • 1.4.6 China Oncology Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Oncology Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Drugs by Major Types

    • 3.4.1 Market Size and Growth Rate of Antimetabolite

    • 3.4.2 Market Size and Growth Rate of Alkaloid drugs

    • 3.4.3 Market Size and Growth Rate of Hormone

    • 3.4.4 Market Size and Growth Rate of Targeted drug

    • 3.4.5 Market Size and Growth Rate of Platinum-based drugs

    • 3.4.6 Market Size and Growth Rate of Other

    4 Segmentation of Oncology Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Oncology Drugs in Blood Cancer

    • 4.4.2 Market Size and Growth Rate of Oncology Drugs in Breast Cancer

    • 4.4.3 Market Size and Growth Rate of Oncology Drugs in Gastrointestinal Cancer

    • 4.4.4 Market Size and Growth Rate of Oncology Drugs in Prostate Cancer

    • 4.4.5 Market Size and Growth Rate of Oncology Drugs in Respiratory/Lung Cancer

    • 4.4.6 Market Size and Growth Rate of Oncology Drugs in Other

    5 Market Analysis by Regions

    • 5.1 China Oncology Drugs Production Analysis by Regions

    • 5.2 China Oncology Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Oncology Drugs Landscape Analysis

    • 6.1 North China Oncology Drugs Landscape Analysis by Major Types

    • 6.2 North China Oncology Drugs Landscape Analysis by Major End-Users

    7 Central China Oncology Drugs Landscape Analysis

    • 7.1 Central China Oncology Drugs Landscape Analysis by Major Types

    • 7.2 Central China Oncology Drugs Landscape Analysis by Major End-Users

    8 South China Oncology Drugs Landscape Analysis

    • 8.1 South China Oncology Drugs Landscape Analysis by Major Types

    • 8.2 South China Oncology Drugs Landscape Analysis by Major End-Users

    9 East China Oncology Drugs Landscape Analysis

    • 9.1 East China Oncology Drugs Landscape Analysis by Major Types

    • 9.2 East China Oncology Drugs Landscape Analysis by Major End-Users

    10 Northeast China Oncology Drugs Landscape Analysis

    • 10.1 Northeast China Oncology Drugs Landscape Analysis by Major Types

    • 10.2 Northeast China Oncology Drugs Landscape Analysis by Major End-Users

    11 Southwest China Oncology Drugs Landscape Analysis

    • 11.1 Southwest China Oncology Drugs Landscape Analysis by Major Types

    • 11.2 Southwest China Oncology Drugs Landscape Analysis by Major End-Users

    12 Northwest China Oncology Drugs Landscape Analysis

    • 12.1 Northwest China Oncology Drugs Landscape Analysis by Major Types

    • 12.2 Northwest China Oncology Drugs Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 HENGRUI

      • 13.1.1 HENGRUI Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 GuiZhou YiBai

      • 13.2.1 GuiZhou YiBai Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Lunan

      • 13.3.1 Lunan Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Eli Lilly and Company

      • 13.4.1 Eli Lilly and Company Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Roche

      • 13.5.1 Roche Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 QILU

      • 13.6.1 QILU Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 LUYE

      • 13.7.1 LUYE Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Novartis

      • 13.8.1 Novartis Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Sanofi

      • 13.9.1 Sanofi Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 AstraZeneca

      • 13.10.1 AstraZeneca Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 HANSOH

      • 13.11.1 HANSOH Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Oncology Drugs Market Size and Growth Rate of Antimetabolite from 2016 to 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Alkaloid drugs from 2016 to 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Hormone from 2016 to 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Targeted drug from 2016 to 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Platinum-based drugs from 2016 to 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Blood Cancer from 2016 to 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Breast Cancer from 2016 to 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Gastrointestinal Cancer from 2016 to 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Respiratory/Lung Cancer from 2016 to 2027

    • Figure China Oncology Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Oncology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Oncology Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Oncology Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Oncology Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Antimetabolite

    • Figure Market Size and Growth Rate of Alkaloid drugs

    • Figure Market Size and Growth Rate of Hormone

    • Figure Market Size and Growth Rate of Targeted drug

    • Figure Market Size and Growth Rate of Platinum-based drugs

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Oncology Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Oncology Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Blood Cancer

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Gastrointestinal Cancer

    • Figure Market Size and Growth Rate of Prostate Cancer

    • Figure Market Size and Growth Rate of Respiratory/Lung Cancer

    • Figure Market Size and Growth Rate of Other

    • Table China Oncology Drugs Production by Regions

    • Table China Oncology Drugs Production Share by Regions

    • Figure China Oncology Drugs Production Share by Regions in 2016

    • Figure China Oncology Drugs Production Share by Regions in 2021

    • Figure China Oncology Drugs Production Share by Regions in 2027

    • Table China Oncology Drugs Consumption by Regions

    • Table China Oncology Drugs Consumption Share by Regions

    • Figure China Oncology Drugs Consumption Share by Regions in 2016

    • Figure China Oncology Drugs Consumption Share by Regions in 2021

    • Figure China Oncology Drugs Consumption Share by Regions in 2027

    • Table North China Oncology Drugs Consumption by Types from 2016 to 2027

    • Table North China Oncology Drugs Consumption Share by Types from 2016 to 2027

    • Figure North China Oncology Drugs Consumption Share by Types in 2016

    • Figure North China Oncology Drugs Consumption Share by Types in 2021

    • Figure North China Oncology Drugs Consumption Share by Types in 2027

    • Table North China Oncology Drugs Consumption by End-Users from 2016 to 2027

    • Table North China Oncology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure North China Oncology Drugs Consumption Share by End-Users in 2016

    • Figure North China Oncology Drugs Consumption Share by End-Users in 2021

    • Figure North China Oncology Drugs Consumption Share by End-Users in 2027

    • Table Central China Oncology Drugs Consumption by Types from 2016 to 2027

    • Table Central China Oncology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Central China Oncology Drugs Consumption Share by Types in 2016

    • Figure Central China Oncology Drugs Consumption Share by Types in 2021

    • Figure Central China Oncology Drugs Consumption Share by Types in 2027

    • Table Central China Oncology Drugs Consumption by End-Users from 2016 to 2027

    • Table Central China Oncology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Oncology Drugs Consumption Share by End-Users in 2016

    • Figure Central China Oncology Drugs Consumption Share by End-Users in 2021

    • Figure Central China Oncology Drugs Consumption Share by End-Users in 2027

    • Table South China Oncology Drugs Consumption by Types from 2016 to 2027

    • Table South China Oncology Drugs Consumption Share by Types from 2016 to 2027

    • Figure South China Oncology Drugs Consumption Share by Types in 2016

    • Figure South China Oncology Drugs Consumption Share by Types in 2021

    • Figure South China Oncology Drugs Consumption Share by Types in 2027

    • Table South China Oncology Drugs Consumption by End-Users from 2016 to 2027

    • Table South China Oncology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South China Oncology Drugs Consumption Share by End-Users in 2016

    • Figure South China Oncology Drugs Consumption Share by End-Users in 2021

    • Figure South China Oncology Drugs Consumption Share by End-Users in 2027

    • Table East China Oncology Drugs Consumption by Types from 2016 to 2027

    • Table East China Oncology Drugs Consumption Share by Types from 2016 to 2027

    • Figure East China Oncology Drugs Consumption Share by Types in 2016

    • Figure East China Oncology Drugs Consumption Share by Types in 2021

    • Figure East China Oncology Drugs Consumption Share by Types in 2027

    • Table East China Oncology Drugs Consumption by End-Users from 2016 to 2027

    • Table East China Oncology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure East China Oncology Drugs Consumption Share by End-Users in 2016

    • Figure East China Oncology Drugs Consumption Share by End-Users in 2021

    • Figure East China Oncology Drugs Consumption Share by End-Users in 2027

    • Table Northeast China Oncology Drugs Consumption by Types from 2016 to 2027

    • Table Northeast China Oncology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Oncology Drugs Consumption Share by Types in 2016

    • Figure Northeast China Oncology Drugs Consumption Share by Types in 2021

    • Figure Northeast China Oncology Drugs Consumption Share by Types in 2027

    • Table Northeast China Oncology Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast China Oncology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Oncology Drugs Consumption Share by End-Users in 2016

    • Figure Northeast China Oncology Drugs Consumption Share by End-Users in 2021

    • Figure Northeast China Oncology Drugs Consumption Share by End-Users in 2027

    • Table Southwest China Oncology Drugs Consumption by Types from 2016 to 2027

    • Table Southwest China Oncology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Oncology Drugs Consumption Share by Types in 2016

    • Figure Southwest China Oncology Drugs Consumption Share by Types in 2021

    • Figure Southwest China Oncology Drugs Consumption Share by Types in 2027

    • Table Southwest China Oncology Drugs Consumption by End-Users from 2016 to 2027

    • Table Southwest China Oncology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Oncology Drugs Consumption Share by End-Users in 2016

    • Figure Southwest China Oncology Drugs Consumption Share by End-Users in 2021

    • Figure Southwest China Oncology Drugs Consumption Share by End-Users in 2027

    • Table Northwest China Oncology Drugs Consumption by Types from 2016 to 2027

    • Table Northwest China Oncology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Oncology Drugs Consumption Share by Types in 2016

    • Figure Northwest China Oncology Drugs Consumption Share by Types in 2021

    • Figure Northwest China Oncology Drugs Consumption Share by Types in 2027

    • Table Northwest China Oncology Drugs Consumption by End-Users from 2016 to 2027

    • Table Northwest China Oncology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Oncology Drugs Consumption Share by End-Users in 2016

    • Figure Northwest China Oncology Drugs Consumption Share by End-Users in 2021

    • Figure Northwest China Oncology Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of HENGRUI

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HENGRUI

    • Figure Sales and Growth Rate Analysis of HENGRUI

    • Figure Revenue and Market Share Analysis of HENGRUI

    • Table Product and Service Introduction of HENGRUI

    • Table Company Profile and Development Status of GuiZhou YiBai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GuiZhou YiBai

    • Figure Sales and Growth Rate Analysis of GuiZhou YiBai

    • Figure Revenue and Market Share Analysis of GuiZhou YiBai

    • Table Product and Service Introduction of GuiZhou YiBai

    • Table Company Profile and Development Status of Lunan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lunan

    • Figure Sales and Growth Rate Analysis of Lunan

    • Figure Revenue and Market Share Analysis of Lunan

    • Table Product and Service Introduction of Lunan

    • Table Company Profile and Development Status of Eli Lilly and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Product and Service Introduction of Eli Lilly and Company

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of QILU

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QILU

    • Figure Sales and Growth Rate Analysis of QILU

    • Figure Revenue and Market Share Analysis of QILU

    • Table Product and Service Introduction of QILU

    • Table Company Profile and Development Status of LUYE

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LUYE

    • Figure Sales and Growth Rate Analysis of LUYE

    • Figure Revenue and Market Share Analysis of LUYE

    • Table Product and Service Introduction of LUYE

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of HANSOH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HANSOH

    • Figure Sales and Growth Rate Analysis of HANSOH

    • Figure Revenue and Market Share Analysis of HANSOH

    • Table Product and Service Introduction of HANSOH


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.